Document is current
Any future updates will be listed below
-
Authors
Elshinnawy, Howaida Abdelhameed https://orcid.org/0000-0002-2015-9698
El-Said, Tamer Wahid https://orcid.org/0000-0002-3458-1734
Fahmy, Sarah Farid https://orcid.org/0000-0001-8402-3434
Shamseldin, Ahmed https://orcid.org/0000-0002-4666-1475
Ibrahim, Sherin https://orcid.org/0000-0003-2430-6293
Elsharabasy, Reem Mohsen https://orcid.org/0000-0002-0812-0870
- License Information
-
More Information
Article History
Received: 5 September 2022
Accepted: 2 December 2022
First Online: 23 January 2023
Declarations
:
: The institutional review board of the ethics committee of the Faculty of Pharmacy, Ain Shams University, revised and approved the study protocol (ENREC-ASU 2020-4). The trial was registered in clinical trial.gov (NCT04145492), and it was performed in accordance with the Declaration of Helsinki, and it also applied CONSORT guidelines and ICMJE recommendations. All caregivers of eligible children were informed about the study protocol and signed written informed consent prior to participation.All patients signed written informed consent to be enrolled in the study and have their results published. The study was approved by the Research Ethical Committee of the Faculty of Medicine, Ain Shams University (ethical committee number: Sid 343) and was following the Helsinki Declaration as revised in 2000. It also applied CONSORT guidelines and ICMJE recommendations. The trial was registered in clinical trials.gov Identifier: NCT04477811.
: The authors declare that they have no competing interests.
